Sign Up Today and Learn More About EarLens Stock
Invest in or calculate the value of your shares in EarLens or other pre-IPO companies through EquityZen's platform.
EarLens Stock (EARL)
EarLens is a medical device company specialized in manufacturing hearing aids
About EarLens Stock
Founded
2005
Headquarters
Menlo Park, CA, US
Total Funding
286M
Industries
Software, Artificial Intelligence, Data and Analytics
EarLens Corporation is a privately held medical device company committed to providing hearing impaired patients a hearing solution that is designed to change the current standard of care for sound performance. The EarLens System's unique mechanism of direct sound delivery potentially opens the door to a level of sound performance achieved by no hearing aid on the market today. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the EarLens Contact Hearing Device™ is the world’s first to use light to transmit sound.
EarLens Press Mentions
Stay in the know about the latest news on EarLens
Contact hearing systems, apparatus and methods
patents • Apr 02, 2025
One piece microactuator membrane
patents • Apr 02, 2025
Modulation in a contact hearing system
patents • Apr 02, 2025
Piezoelectric transducer for tympanic membrane
patents • Apr 02, 2025
Tympanic lens for hearing device with reduced fluid ingress
patents • Apr 02, 2025
EarLens Management
Leadership team at EarLens
CTO
Brent Edwards
Founder and Chief Medical Officer
Dr. Rodney Perkins
Join now and verify your accreditation status to gain access to:
- EarLens Current Valuation
- EarLens Stock Price
- EarLens Management
- Available deals in EarLens and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- EarLens Cap Table and Funding History by Share Class and Liquidity Preferences
- EarLens Revenue and Financials
- EarLens Highlights
- EarLens Business Model
- EarLens Risk Factors
- EarLens Research Report from SACRA Research
Trading EarLens Stock
How to invest in EarLens stock?
Accredited investors can buy pre-IPO stock in companies like EarLens through EquityZen funds. These investments are made available by existing EarLens shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell EarLens stock?
Shareholders can sell their EarLens stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
